Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of the Combination of High-Dose Methotrexate and Intrathecal Liposomal Cytarabine in Patients With Leptomeningeal Metastases With or Without Parenchymal Brain Involvement

NCT00992602 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT00992602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00992602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of the Combination of High-Dose Methotrexate and Intrathecal Liposomal Cytarabine in Patients With Leptomeningeal Metastases With or Without Parenchymal Brain Involvement
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2011
Completion date
October 31, 2014
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central nervous system metastases, leptomeningeal metastases, recurrent breast cancer, stage iv breast cancer, tumors metastatic to brain